THROMBOGENICS NV has a total of 100 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are SHIRE PHARMACEUTICALS IRELAND LTD, ZYMENEX AS and SWEDISH ORPHAN BIOVITRUM AB PUBL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 14 | |
#2 | United States | 14 | |
#3 | WIPO (World Intellectual Property Organization) | 10 | |
#4 | Australia | 7 | |
#5 | Israel | 7 | |
#6 | China | 6 | |
#7 | New Zealand | 6 | |
#8 | Canada | 5 | |
#9 | Republic of Korea | 5 | |
#10 | Mexico | 5 | |
#11 | Brazil | 4 | |
#12 | Hong Kong | 3 | |
#13 | Japan | 3 | |
#14 | Russian Federation | 3 | |
#15 | Norway | 2 | |
#16 | South Africa | 2 | |
#17 | EAPO (Eurasian Patent Organization) | 1 | |
#18 | India | 1 | |
#19 | Luxembourg | 1 | |
#20 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes | |
#7 | Analysing materials | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Zwaal Richard Reinier | 29 |
#2 | Pakola Steve | 17 |
#3 | De Smet Marc | 16 |
#4 | Ngo Hoa Thu | 13 |
#5 | Zwaal Richard | 13 |
#6 | Fromond Claudia | 12 |
#7 | Stassen Jean-Marie | 12 |
#8 | Collen Desire | 11 |
#9 | Notebaert Sofie | 11 |
#10 | Carmeliet Peter | 9 |
Publication | Filing date | Title |
---|---|---|
IL235188D0 | Anti-pdgf-c antibodies | |
NZ724395A | Anti-pdgf-c antibodies | |
AU2013205649A1 | Improving trabeculectomy outcome | |
WO2013139956A1 | Antibodies abrogating cell binding to lactadherin | |
CN103764163A | Plasminogen and plasmin variants | |
CN103384722A | Plasminogen and plasmin variants | |
EP2480249A1 | Plasmin for the treatment of filtration failure after trabeculectomy | |
BR112012000650A2 | "plasminogen and plasmin variants" | |
NZ597452A | Variants of plasminogen and plasmin | |
CN101848928A | Staphylokinase variant | |
EP2009026A1 | Anti-VPAC1 antibodies and their uses | |
AU2004264265A1 | Antibodies against factor VIII with modified glycosylation in the variable region |